2008 ACC/AHA Clinical Performance Measures for Adults
with ST-Elevation and Non-ST-Elevation Myocardial Infarction
30-Day Public Comment Period

June 23, 2008 - July 22, 2008

Go to the Public Comment/Reviewer Response Form

 

Thank you for your interest in reviewing this draft version of the 2008 ACC/AHA Clinical Performance Measures for Adults with ST-Elevation and Non-ST-Elevation Myocardial Infarction. This document is an update of the 2006 ACC/AHA STEMI/NSTEMI Performance Measure set.

This updated measure set is based upon the 2004 ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction, the 2007 Focused Update of the ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction and the 2007 ACC/AHA Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction.

Certain highly rated therapies or strategies were not included in this performance measure set. The Writing Committee sought to include only those with the strongest evidence and which satisfied all the criteria set forth in the methodology for the development of performance measures. We consider this effort to be an iterative process and there will be a need to continue to refine and improve the set in the future.



 
 

2008 ACC/AHA Clinical Performance Measures for Adults
with ST-Elevation and Non-Elevation Myocardial Infarction

 

Please read the steps below and then complete the form which follows.

Step 1: Review the Document

Full-text document (Adobe Acrobat pdf file): 2008 ACC/AHA Clinical Performance Measures for Adults with ST-Elevation and Non-Elevation Myocardial Infarction.



ACC's privacy statement |   AHA's privacy statement

 

Step 2: Demographics

Please complete the information below.  [*indicates mandatory field]

*First Name:  *Last Name: 
Title:  *Organization: 
*Address 1:  Address 2: 
*City/State/Country/Zip:  *Email Address: 
*Responder Category: 
 
Comments submitted represent the opinion of.   [*select one option]
The organization listed above. *
Myself as an individual. *
 
Step 3: Relationships with Industry
 
All members of ACC/AHA performance measures writing committees, as well as peer and public comment reviewers for ACC/AHA performance measures, are required to provide relevant “Relationship with Industry” information.  Please read the STEMI_NSTEMI RWI Disclosure Statement before completing the information below.

I have already submitted my annual disclosure online at http://www.acc.org/disclosure/. If "Yes", please skip to Step 4: Provide General Comments.
I have relationships with industry to disclose. If "Yes", please list below.

1. Company: 
   Type of Relationship: Amount:
2. Company: 
   Type of Relationship: Amount:
3. Company: 
   Type of Relationship: Amount:
4. Company: 
   Type of Relationship: Amount:
5. Company: 
   Type of Relationship: Amount:
6. Company: 
   Type of Relationship: Amount:
7. Company: 
   Type of Relationship: Amount:
8. Company: 
   Type of Relationship: Amount:
9. Company: 
   Type of Relationship: Amount:
10. Company: 
   Type of Relationship: Amount:

If you have questions or problems with this form, call Melanie Shahriary at 202-375-6662.

Step 4: Provide General Comments

Please provide general comments regarding the full-text document, 2008 ACC/AHA Clinical Performance Measures for Adults with ST-Elevation and Non-Elevation Myocardial Infarction (Adobe Acrobat pdf), below, including whether the text and supplemental information included with the performance measure set is sufficient to explain the purpose, methodology, and potential uses of this document. Please include page and line numbers from the document where applicable. IMPORTANT: Do not comment on individual measures here. Please use the individual measure comment boxes in Step 5 below.
Char Left: Exceeded maximum number of characters.



Step 5: Rate the Performance Measures

IMPORTANT: Please review the STEMI_NSTEMI Rating Form Guide before commenting on the individual measures in the 2008 ACC/AHA Clinical Performance Measures for Adults with ST-Elevation and Non-Elevation Myocardial Infarction . Please provide specific comments on the degree to which the measures demonstrate the attributes of good performance measures as outlined in the Rating Form Guide.
 
 
1. Aspirin at Arrival:

Char Left:  Exceeded maximum number of characters.
 
2. Aspirin Prescribed at Discharge:

Char Left:  Exceeded maximum number of characters.
 
3. Beta Blocker at Arrival:

Char Left:  Exceeded maximum number of characters.
 
4. Beta Blockers Prescribed at Discharge:

Char Left:  Exceeded maximum number of characters.
 
5. Statin at Discharge:

Char Left:  Exceeded maximum number of characters.
 
6. Evaluation of Left Ventricular Systolic Function :

Char Left:  Exceeded maximum number of characters.
 
7.ACEI or ARB for LVSD:

Char Left:  Exceeded maximum number of characters.
 
8. Time to Fibrinolytic Therapy:

Char Left:  Exceeded maximum number of characters.
 
9. Time to PCI:

Char Left:  Exceeded maximum number of characters.
 
10. Reperfusion Therapy:

Char Left:  Exceeded maximum number of characters.
 
11. Time from ED Arrival to ED Discharge in Patients Transferred for Primary PCI:

Char Left:  Exceeded maximum number of characters.
 
12. Time to Primary PCI among Transferred Patients:

Char Left:  Exceeded maximum number of characters.
 
13. Adult Smoking Cessation Advice/Counseling:

Char Left:  Exceeded maximum number of characters.
 
14. Cardiac Rehabilitation Patient Referral From an Inpatient Setting:

Char Left:  Exceeded maximum number of characters.
 
15. Test Measure: T-1. LDL Cholesterol Assessment:

Char Left:  Exceeded maximum number of characters.
 
16. Test Measure: T-2, T-3, T-4 and T-5: Excess Dosing of Anticoagulants or IV antiplatelets

Char Left:  Exceeded maximum number of characters.
 
17. Test Measure: T-6 & T-7: Anticoagulant Dosing Structural Measures

Char Left:  Exceeded maximum number of characters.
 
18. Test Measure: T-8. Clopidogrel at Discharge for Medically Treated AMI Patients

Char Left:  Exceeded maximum number of characters.
 
Step 6: Possible endorsement:

Please indicate below whether your organization would be interested in considering endorsement of ACC/AHA Performance Measures for Primary Prevention of Cardiovascular Disease once finalized. We will contact you with further information.

If you have questions or problems with this form, call Melanie Shahriary at 202-375-6662.
 Yes, my organization would like to consider endorsing the final measure set.
Contact Name:
Phone number:
E-mail address:
 No, my organization is not interested in endorsing these measures.
 

 
 
 
 
 
Back to Top | | Copyright © 2008 American College of Cardiology
Heart House | 2400 N Street, NW | Washington, DC 20037